Vestal Point Capital, LP Passage Bio, Inc. Transaction History
Vestal Point Capital, LP
- $1.4 Trillion
- Q1 2025
A detailed history of Vestal Point Capital, LP transactions in Passage Bio, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 6,100,000 shares of PASG stock, worth $38.2 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
6,100,000
Previous 6,100,000
-0.0%
Holding current value
$38.2 Million
Previous $3.46 Billion
37.74%
% of portfolio
0.15%
Previous 0.21%
Shares
3 transactions
Others Institutions Holding PASG
# of Institutions
43Shares Held
36.4MCall Options Held
50.3KPut Options Held
0-
Lynx1 Capital Management LP San Juan, PR9.26MShares$58 Million1.2% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.03MShares$44.1 Million0.08% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$15.7 Million1.97% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.46MShares$15.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$13 Million0.0% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $341M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...